Mar 18, 2016 Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy. Paul S1, Shuja A2, Tam I3, Kim EM3, Kang S4, Kapulsky L4, Viveiros K3, Lee H5. Abstract BACKGROUND AND AIMS: Hepatitis B reactivation in patients undergoing immunosuppressive therapy can lead to liver failure and…
Read MoreSeyed Moayed Alavian, [27.03.16 16:42] [Forwarded from Global Hepatitis Community] Biotech and Pharmaceuticals NEWS: Gilead ordered to pay Merck $200M for patent infringement Friday, 25 Mar 2016 The federal jury in a patent trial has ordered drugmaker Gilead Sciences to pay Merck $200 million in damages for infringing on patents…
Read More
March 11, 2016 An estimated 2.3 million people around the world are currently living with both HIV and hepatitis C virus (HCV), more than half of whom are people who inject drugs, show new findings published online in The Lancet Infectious Diseases. Sponsored by the World Health Organization (WHO), the…
Read More
March 11, 2016 A high HIV viral load and a low CD4 count are each independently associated with liver fibrosis progression among people living with the virus, including those who are coinfected with hepatitis B or C viruses (HBV/HCV). Researchers analyzed data on 14,198 HIV-positive individuals in medical care between…
Read More
March 10, 2016 The severity of liver fibrosis is associated with cognitive dysfunction independent of hepatitis C virus (HCV) or HIV status, at least among women living with one or both viruses. Researchers conducted a cross-sectional study of 1,479 women from the Women’s Interagency HIV Study (WIHS) and presented their…
Read More
March 9, 2016 Bucking the national trend of declining overall cancer rates, liver cancer incidence is quickly rising in the United States, driven by hepatitis B and C virus (HBV and HCV) infection in an aging population. The Centers for Disease Control and Prevention (CDC), the American Cancer Society, the…
Read More
March 9, 2016 While a large scale-up of hepatitis C virus treatment among current and former injection drug users (IDUs) would reduce HCV prevalence, a truly massive scale-up would be required to actually drive down the rate of new infections among the population. Researchers conducted a model of hep C…
Read More
March 8, 2016 According to a recent study, HIV-positive people who contract hepatitis C virus have an increased risk of kidney disease and osteoporosis, even if they spontaneously clear HCV or are cured of the virus. Researchers analyzed data on HIV-positive members of the Swiss HIV Cohort Study, comparing 2,503…
Read More
March 7, 2016 Drinking at least three cups of coffee a day is linked with a lowered risk of death among people coinfected with HIV and hepatitis C virus (HCV). Researchers analyzed data from from the ANRS C013 HEPAVIH cohort, a French nationwide prospective cohort of HIV/HCV-coinfected individuals who provided…
Read More
March 7, 2016 People with hepatitis C virus (HCV) very rarely experience a relapse of the virus following acheiving a sustained virologic response 12 weeks after completing treatment (SVR12, considered a cure), Reuters Health reports. However, certain populations of those treated for the virus are at high risk of reinfection.…
Read More